CL2012003136A1 - Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina). - Google Patents

Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina).

Info

Publication number
CL2012003136A1
CL2012003136A1 CL2012003136A CL2012003136A CL2012003136A1 CL 2012003136 A1 CL2012003136 A1 CL 2012003136A1 CL 2012003136 A CL2012003136 A CL 2012003136A CL 2012003136 A CL2012003136 A CL 2012003136A CL 2012003136 A1 CL2012003136 A1 CL 2012003136A1
Authority
CL
Chile
Prior art keywords
methyl
dimethoxycycle
ivabradine
benzazepin
trien
Prior art date
Application number
CL2012003136A
Other languages
English (en)
Spanish (es)
Inventor
Renaud Jean-Luc
Pannetier Nicolas
Lecouve Jean-Pierre
Vaysse-Ludot Lucile
Moulin Solenne
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47115640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012003136(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CL2012003136A1 publication Critical patent/CL2012003136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2235/00—Indexing scheme associated with group B01J35/00, related to the analysis techniques used to determine the catalysts form or properties
    • B01J2235/05—Nuclear magnetic resonance [NMR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2012003136A 2011-12-20 2012-11-08 Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina). CL2012003136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1103933A FR2984319B1 (fr) 2011-12-20 2011-12-20 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
CL2012003136A1 true CL2012003136A1 (es) 2014-08-01

Family

ID=47115640

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003136A CL2012003136A1 (es) 2011-12-20 2012-11-08 Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina).

Country Status (34)

Country Link
US (1) US8513410B2 (enExample)
EP (1) EP2607353B1 (enExample)
JP (1) JP5670406B2 (enExample)
KR (1) KR101470879B1 (enExample)
CN (1) CN103172566B (enExample)
AR (1) AR088678A1 (enExample)
AU (1) AU2012244188B2 (enExample)
BR (1) BR102012028614A2 (enExample)
CA (1) CA2795741C (enExample)
CL (1) CL2012003136A1 (enExample)
CY (1) CY1115682T1 (enExample)
DK (1) DK2607353T3 (enExample)
EA (1) EA026510B1 (enExample)
ES (1) ES2525032T3 (enExample)
FR (1) FR2984319B1 (enExample)
GE (1) GEP20156350B (enExample)
HR (1) HRP20141023T1 (enExample)
JO (1) JO3031B1 (enExample)
MA (1) MA34276B1 (enExample)
MD (1) MD4336C1 (enExample)
MX (1) MX2012012938A (enExample)
MY (1) MY170662A (enExample)
PE (1) PE20131097A1 (enExample)
PL (1) PL2607353T3 (enExample)
PT (1) PT2607353E (enExample)
RS (1) RS53541B1 (enExample)
SA (1) SA112330994B1 (enExample)
SG (1) SG191471A1 (enExample)
SI (1) SI2607353T1 (enExample)
TW (1) TWI440627B (enExample)
UA (1) UA111329C2 (enExample)
UY (1) UY34423A (enExample)
WO (1) WO2013093220A1 (enExample)
ZA (1) ZA201208160B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN105669554A (zh) * 2016-02-22 2016-06-15 徐建立 一种盐酸伊伐布雷定杂质及其制备方法和应用
FR3071833B1 (fr) * 2017-09-29 2020-01-03 Universite Paris-Sud Nouveau procede de synthese d'amines tertiaires dissymetriques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US6225487B1 (en) * 1998-04-17 2001-05-01 Symyx Technologies, Inc. Ancillary ligands and metal complexes, catalysts and compositions using same and methods of testing
US6521793B1 (en) * 1998-10-08 2003-02-18 Symyx Technologies, Inc. Catalyst ligands, catalytic metal complexes and processes using same
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP1595888A1 (en) * 2004-05-11 2005-11-16 Degussa AG Cycloolefin phosphine ligands and their use in catalysis
ES2381771T3 (es) * 2006-11-30 2012-05-31 Cadila Healthcare Limited Procedimiento para la preparación de hidrocloruro de ivabradina
US8212026B2 (en) * 2007-05-30 2012-07-03 Ind-Swift Laboratories Limited Process for the preparation of ivabradine hydrochloride and polymorph thereof
US7857994B2 (en) 2007-05-30 2010-12-28 GE Lighting Solutions, LLC Green emitting phosphors and blends thereof
FR2920773B1 (fr) 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
CN103172566A (zh) 2013-06-26
MY170662A (en) 2019-08-26
ZA201208160B (en) 2013-06-26
EP2607353A1 (fr) 2013-06-26
AU2012244188A1 (en) 2013-07-04
SA112330994B1 (ar) 2015-08-03
AU2012244188B2 (en) 2015-07-30
CN103172566B (zh) 2015-11-18
UY34423A (es) 2013-07-31
MA34276B1 (fr) 2013-06-01
EP2607353B1 (fr) 2014-08-27
CA2795741A1 (fr) 2013-06-20
DK2607353T3 (en) 2014-12-08
JO3031B1 (ar) 2016-09-05
RS53541B1 (sr) 2015-02-27
TWI440627B (zh) 2014-06-11
SI2607353T1 (sl) 2014-12-31
CA2795741C (fr) 2015-09-08
HRP20141023T1 (hr) 2014-12-05
JP2013129650A (ja) 2013-07-04
EA026510B1 (ru) 2017-04-28
UA111329C2 (uk) 2016-04-25
KR101470879B1 (ko) 2014-12-09
HK1186733A1 (zh) 2014-03-21
MD4336B1 (ro) 2015-03-31
PT2607353E (pt) 2014-10-10
FR2984319B1 (fr) 2013-12-27
PL2607353T3 (pl) 2015-01-30
KR20130071350A (ko) 2013-06-28
BR102012028614A2 (pt) 2014-12-16
CY1115682T1 (el) 2017-01-25
MX2012012938A (es) 2013-06-19
WO2013093220A1 (fr) 2013-06-27
NZ603483A (en) 2014-02-28
US8513410B2 (en) 2013-08-20
PE20131097A1 (es) 2013-10-12
SG191471A1 (en) 2013-07-31
TW201326132A (zh) 2013-07-01
MD4336C1 (ro) 2015-10-31
FR2984319A1 (fr) 2013-06-21
JP5670406B2 (ja) 2015-02-18
EA201201385A1 (ru) 2013-06-28
AR088678A1 (es) 2014-06-25
ES2525032T3 (es) 2014-12-16
GEP20156350B (en) 2015-08-25
US20130158256A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
PL2166004T3 (pl) Nowy sposób rozdzielania enancjomerów (3,4-dimetoksy-bicyklo[4.2.0]okta -1,3,5-trien -7-ylo)nitrylu i ich zastosowanie do syntezy iwabradyny
IL222365A (en) 2,2 '- ({[3-Butyl-3-Ethyl-7- (Methyloxy) -1,1-Dioxide-5-Phenyl-5,4,3,2-Tetra Hydro-1, 4-Benzothiazepine-8 Methyl (imino) acetic acid
IL216921A0 (en) Electrospinning of polyamide nanofibers
PL2255587T3 (pl) Filtrowanie fałszywych alarmów przy pół-trwałym planowaniu
SI2921168T1 (sl) Sestavek n-(((7s)-3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il)metil)-3-( 7,8-dimetoksi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-okso-1- propanamina in perindoprila
EA201190034A1 (ru) Полиморфы (s)-3-аминометил-7-(3-гидроксипропокси)-3н-бензо[c][1,2]оксаборол-1-ола
NZ594087A (en) Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
PL1924561T3 (pl) 6-aryloalkiloamino-2,3,4,5-tetrahydro-1h-benzo[d]azepiny jako agoniści receptora 5-ht2c
CL2012003136A1 (es) Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina).
GEP20135970B (en) New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof
ZA201101579B (en) Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
EA201001353A1 (ru) Гидробромид ивабрадина
EA200800022A3 (ru) Применение ивабрадина для получения лекарственного средства, предназначенного для лечения эндотелиальной дисфункции
CL2011000297A1 (es) Procedimiento de sintesis de ivabradina utilizando un intermediario de hemitioacetal; y los compuestos intermediarios considerados.
GEP20156235B (en) Process for enzymatic synthesis of (7s)-3,4-dimethoxy-bicyclo-[4.2.0]octa-1,3,5-triene-7- carboxylic acid or esters thereof, and application in synthesis of ivabradine and salts thereof
MD4375B1 (ro) Procedeu de sinteză enzimatică a (7S)-1-(3,4-dimetoxibiciclo¢4.2.0]octa-1,3,5-trien-7-il)-N-metil-metanaminei şi aplicarea în sinteza ivabradinei şi a sărurilor sale
AR070416A1 (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante
BR112015028928A2 (pt) processo para preparar cloridrato de ivabradina e uso de cloridrato de 3-[3-[[[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metilamino]propil]-1,3-diidro-7,8-dimetoxi-2h-3-benzazepin-2-ona (cloridrato de desidro-ivabradina)
MD20130016A2 (en) New process for the synthesis of ivabradine and addition salts thereof with pharmaceutically acceptable acids
EA200901369A1 (ru) Применение ивабрадина в качестве диагностического средства в методе коронарной ангиографии путем многослойной компьютерной томографии
NZ622915A (en) Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine
IL212749A0 (en) Novel forms of an indazolo [5,4-a] carbazole compound
WO2013017937A8 (en) Process for the manufacture of ivabradine and of intermediates of synthesis thereof
HRP20150950T1 (en) Method for enzymatic synthesis of (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid, and use for the synthesis of ivabradine and the salts thereof
TH137164A (th) การใช้ประโยชน์จากการร่วมกันของสารยับยั้งกระแสไซนัสโหนด If (sinus node If current inhibitor) และสารยับยั้งเอนไซม์ซึ่งเปลี่ยนผันแองจิโอเทนซิน (angiotensin-converting enzyme inhibitor) ในการบำบัดภาวะหัวใจล้มเหลว